The I-Cell model: the molecular basis for abnormal lysosomal enzyme transport in mucolipidosis II and mucolipidosis III

Author(s):  
William S. Sly ◽  
Vasantha Sundaram
2020 ◽  
Vol 129 (2) ◽  
pp. S125-S126
Author(s):  
Dao Pan ◽  
Yi Lin ◽  
Xiaohong Wang ◽  
Kevin Rose ◽  
Mei Dai ◽  
...  

1996 ◽  
Vol 24 (1) ◽  
pp. 133-136 ◽  
Author(s):  
H. Munier-Lehmann ◽  
F. Mauxion ◽  
B. Hoflack

2019 ◽  
Vol 7 (1) ◽  
pp. 6-15
Author(s):  
Jaime Cárcel-Trullols

Background: Juvenile neuronal ceroid lipofuscinosis (JNCL), one of the most frequent forms of the NCL storage diseases, is known to be caused by loss-of-function mutations in ceroid-lipofuscinosis neuronal protein 3 (CLN3), but its cell function has not been fully elucidated. We previously reported increased lysosomal pH in CLN3 deficient cells. In the present study, we analysed the consequences of this effect in the endo-lysosomal pathways in CLN3 cells. Methods: The present study investigated different endo-lysosomal pathways in control, CLN2, CLN3 human skin fibroblasts under high and low proteolysis conditions. Cell surface biotinylation after EGF (2 ng/mL) stimulation, EGF phosphorylation (Tyr-845), retromer and cation-independent mannose-6- phosphate receptor (CI-MPR) levels and stability, EGF degradation pathways and cathepsin L and D levels were analysed by western blots. Caveolae mediated endocytosis was analysed by flow cytometry. CIMPR subcellular localization was ascertained by immunocytochemistry, confocal microscopy and further image analysis. Results: Whereas caveolae-mediated endocytosis was not affected in CLN3 cells, clathrin-mediated epidermal growth factor (EGF) internalization was reduced, along with EGF receptor (EGFR) phosphorylation. In addition, cell surface EGFR levels and recycling to the cell membrane were increased. EGFR lysosomal degradation was impaired and our results suggest that the receptor was diverted to proteasomal degradation. We also analysed the machinery responsible for lysosomal hydrolase transport to the lysosome and found increased stability of CIMPR, a major receptor implicated in the transport of hydrolases. The subcellular distribution of the CI-MPR was also altered in CLN3 cells, since it accumulated within the Trans-Golgi network (TGN) and did not progress into the lysosomes. In addition, we found a reduced turnover of retromer subunits, a complex that retrieves the CI-MPR from endosomes to the TGN. Finally and as a possible consequence of these alterations in lysosomal enzyme transport, cathepsin L and D maturation were found suppressed in CLN3 cells. Conclusion: Altogether, these results point to increased lisosomal pH as a pivotal event causing various alterations in intracellular traffic associated to the development of JNCL disease.


1983 ◽  
Vol 72 (3) ◽  
pp. 1016-1023 ◽  
Author(s):  
O T Mueller ◽  
N K Honey ◽  
L E Little ◽  
A L Miller ◽  
T B Shows

Leukemia ◽  
2017 ◽  
Vol 32 (4) ◽  
pp. 941-951 ◽  
Author(s):  
S Bornschein ◽  
S Demeyer ◽  
R Stirparo ◽  
O Gielen ◽  
C Vicente ◽  
...  

2015 ◽  
Vol 36 (3) ◽  
pp. 476-486 ◽  
Author(s):  
Akihiko Urayama ◽  
Jeffrey H Grubb ◽  
William S Sly ◽  
William A Banks

The adult blood–brain barrier, unlike the neonatal blood–brain barrier, does not transport lysosomal enzymes into brain, making enzyme replacement therapy ineffective in treating the central nervous system symptoms of lysosomal storage diseases. However, enzyme transport can be re-induced with alpha-adrenergics. Here, we examined agents that are known to alter the blood–brain barrier transport of large molecules or to induce lysosomal enzyme transport across the blood–brain barrier ((±)epinephrine, insulin, retinoic acid, and lipopolysaccharide) in 2-week-old and adult mice. In 2-week-old adolescent mice, all these pharmacologic agents increased brain and heart uptake of phosphorylated human β-glucuronidase. In 8-week-old adult mice, manipulations with (±)epinephrine, insulin, and retinoic acid were significantly effective on uptake by brain and heart. The increased uptake of phosphorylated human  β-glucuronidase was inhibited by mannose 6-phosphate for the agents (±)epinephrine and retinoic acid and by L-NG-nitroarginine methyl ester for the agent lipopolysaccharide in neonatal and adult mice. An in situ brain perfusion study revealed that retinoic acid directly modulated the transport of phosphorylated human β-glucuronidase across the blood–brain barrier. The present study indicates that there are multiple opportunities to at least transiently induce phosphorylated human β-glucuronidase transport at the adult blood–brain barrier.


1998 ◽  
Vol 3 (2) ◽  
pp. 80-86 ◽  
Author(s):  
Kathi C. Madison ◽  
Gloria N. Sando ◽  
Elizabeth J. Howard ◽  
Cheryl A. True ◽  
Delon Gilbert ◽  
...  

Endocytosis ◽  
1992 ◽  
pp. 197-203
Author(s):  
Thomas Ludwig ◽  
Stéphane Méresse ◽  
Bernard Hoflack

Sign in / Sign up

Export Citation Format

Share Document